Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-2 of 2 for your search:
Drug:
buthionine sulfoximine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I Study of Melphalan and Buthionine Sulfoximine Followed By Autologous Bone Marrow or Peripheral Blood Stem Cell Support in Children With Resistant or Recurrent High-Risk Neuroblastoma
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Over 9 months to 30 years
Sponsor:
Other
Protocol IDs:
NANT-99-02
, 68, N99-02, CHLA-LA-NANT-99-02, CHLA-CCI-00.020, NCT00005835
2.
Phase I Study of Buthionine Sulfoximine in Combination With Normothermic Isolated Limb Infusion of Melphalan in Patients With Persistent or Recurrent Stage IIIB or IIIC In-Transit Malignant Melanoma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DUMC-PRO00001793
, Pro00001793, NCT00661336
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute